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Pyk2 modulates hippocampal excitatory synapses
and contributes to cognitive deﬁcits in a
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The structure and function of spines and excitatory synapses are under the dynamic control
of multiple signalling networks. Although tyrosine phosphorylation is involved, its regulation
and importance are not well understood. Here we study the role of Pyk2, a non-receptor
calcium-dependent protein-tyrosine kinase highly expressed in the hippocampus.
Hippocampal-related learning and CA1 long-term potentiation are severely impaired in
Pyk2-deﬁcient mice and are associated with alterations in NMDA receptors, PSD-95 and
dendritic spines. In cultured hippocampal neurons, Pyk2 has autophosphorylation-dependent
and -independent roles in determining PSD-95 enrichment and spines density. Pyk2 levels are
decreased in the hippocampus of individuals with Huntington and in the R6/1 mouse model of
the disease. Normalizing Pyk2 levels in the hippocampus of R6/1 mice rescues memory
deﬁcits, spines pathology and PSD-95 localization. Our results reveal a role for Pyk2 in spine
structure and synaptic function, and suggest that its deﬁcit contributes to Huntington’s
disease cognitive impairments.
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S
ynaptic function and plasticity, as well as spine morphology
are regulated by multiple signalling pathways that integrate
the diversity of signals converging on synapses. Receptors
for neurotransmitters, as well as numerous other post-synaptic
proteins are phosphorylated by a variety of serine/threonine
protein kinases, many of which have been extensively investi-
gated, especially in the context of synaptic plasticity. Tyrosine
kinases have also been reported to contribute to the regulation
of post-synaptic proteins, including regulation of NMDA
(N-methyl-D-aspartate) glutamate receptors by Src family kinases
(SFKs) and proline-rich tyrosine kinase 2 (Pyk2)1,2. However, the
functional importance of these regulations in vivo is unknown.
Pyk2 is a non-receptor tyrosine kinase that can be activated by
Ca2þ and is highly expressed in forebrain neurons, especially in
the hippocampus3,4. Previous ﬁndings indicated a role for Pyk2 in
synaptic plasticity1,5–7 and its gene, PTK2B, is a susceptibility
locus for Alzheimer’s disease8. Pyk2 is activated by Ca2þ , and
although the mechanism has not been fully elucidated, it probably
involves dimer assembly9, which triggers its autophosphorylation
at Tyr402 and the recruitment of SFKs10. Tyr402 phosphorylation
is increased by neuronal depolarization11 and tetanic stimulation7
in hippocampal slices, and by activation of NMDA5 or group I
metabotropic12 glutamate receptors in cultured hippocampal
neurons. Pyk2 and SFKs are part of the NMDA receptor
complex7,13 and Pyk2 interacts directly with post-synaptic
density (PSD) proteins PSD95 (ref. 14), SAP102 (ref. 14) and
SAPAP3 (ref. 15). Long-term potentiation (LTP) of CA1 synapses
requires protein tyrosine phosphorylation16,17 and is prevented
by a kinase-dead Pyk2 (ref. 7) or by competition of Pyk2:PSD95
interaction5. These results led to the suggestion of a role of Ca2þ -
induced activation of Pyk2 in regulating NMDA receptor
function and synaptic plasticity, likely through recruitment of
SFKs1,2. However, the functional relevance of these ﬁndings
in vivo is not known and the role of Pyk2 in hippocampal
physiology or pathology has not been investigated. Pyk2
knockout mice display a mild immunological phenotype but
their nervous system has not been studied18.
Here we show that the inactivation of one or two alleles of the
Ptk2b gene in mice does not alter hippocampal development but
prevents hippocampal-dependent memory tasks and LTP. We
provide evidence for multiple roles of Pyk2 in spine morphology
and post-synaptic structure. Moreover, we show that Pyk2 is
decreased in the hippocampus of patients with Huntington’s
disease (HD), an inherited neurodegenerative disorder, which
results from the expansion of a CAG trinucleotide repeat in the
huntingtin (Htt) gene19. Pyk2 is also decreased in R6/1 mice,
which express a mutated form of Htt, and these mice display a
hippocampal phenotype similar to that observed in Pyk2 mutant
mice. This phenotype is partly rescued by restoring Pyk2 levels in
R6/1 mice, suggesting a reversible role of Pyk2 deﬁcit in the HD
mouse model.
Results
Pyk2 knockout impairs hippocampal-dependent memory and LTP.
To study the role of Pyk2 in the brain, we used a knockout mouse
line20 that we recently generated. As previously observed for a
similar line18, these mice bred normally and there were no
differences between Pyk2þ /þ , Pyk2þ / and Pyk2 / mice in
body weight, muscular strength, general locomotor activity or
anxiety levels evaluated in the elevated plus-maze (Supplementary
Fig. 1a–d). We tested Pyk2þ /þ , Pyk2þ / and Pyk2 /
littermate mice in two simple tasks that depend on
hippocampus-mediated spatial memory21,22. In the Y-maze
spontaneous alternation task, Pyk2þ /þ mice showed a
signiﬁcant preference for the new arm 2 h after exposure to the
other arm, whereas both Pyk2þ / and Pyk2 / littermates
explored equally both arms (Fig. 1a). In the novel object location
(NOL) test, 24 h after a ﬁrst exposure, wild-type mice spent more
time exploring the object placed at a new location (Fig. 1b). In
contrast, both Pyk2þ / and Pyk2 / mice did not display any
preference for either object (Fig. 1b). These results revealed
spatial memory deﬁcits in both heterozygous and homozygous
mutant mice.
We next examined whether these behavioural deﬁcits were
accompanied by altered synaptic plasticity in hippocampal slices.
We restricted our study to CA1, a hippocampal region extensively
implicated in spatial learning. High-frequency conditioning
tetanus of Schaffer collaterals (5 1 s at 100Hz) induced LTP
in CA1 of wild-type mice (Fig. 1c). In contrast, no LTP was
observed in slices from Pyk2þ / or Pyk2 / mice (Fig. 1c,d).
We also examined a form of short-term plasticity at the same
synapses. Paired-pulse facilitation was observed in wild-type mice
but was markedly decreased in both homozygous and hetero-
zygous Pyk2 mutant mice (Fig. 1e and Supplementary Fig. 1e),
suggesting the existence of a presynaptic role of Pyk2. Taken
together, these results show that deletion of Pyk2 impairs
hippocampus-dependent memory and synaptic plasticity in
CA1. Importantly, the heterozygous mutation of Pyk2 was as
severe as the full deletion, indicating that Pyk2 levels may be
limiting for hippocampal plasticity.
Alteration in NMDA receptors and PSD-95 in Pyk2 mutant mice.
To explore the molecular consequences of Pyk2 deﬁcit, we
examined the levels of proteins previously associated with the
Pyk2 pathway at synapses by immunoblotting. In hippocampal
tissue of Pyk2þ / mice, Pyk2 protein was decreased by about
50% as compared to wild-type littermates, and was not detectable
in Pyk2 / mice (Fig. 2a,b). No N-terminal truncated fragment
was detected in the knockout mice (Supplementary Fig. 2a),
showing that deletion of exons 15–18 in the Pyk2 gene20
destabilized the resulting mRNA and/or protein. There was no
compensatory alteration of the related focal adhesion kinase
(FAK, Fig. 2a,b). In both Pyk2þ / and Pyk2 / mice, the
activated form of SFKs (pY-SFK, pTyr420 in Fyn) was markedly
reduced, whereas Fyn levels were unchanged (Fig. 2a,b),
underlining the contribution of Pyk2 in regulating SFKs
phosphorylation. In contrast, there was no change in the basal
phosphorylation (activation) of ERK1/2 (Supplementary
Fig. 2b,c), reported to be downstream of Pyk2 in some cell
systems10, including in hippocampal neurons in culture6, but not
in adult slices23. We then focused on glutamate receptors.
We found no consistent change between genotypes in GluA1 and
GluA2 AMPA receptors subunits, or in their phosphorylated
forms pSer831-GluA1 and pTyr876-GluA2 (Supplementary
Fig. 2d,e). NMDA receptors GluN1 levels were not changed
either (Fig. 2d,e). In contrast, we observed marked alterations
of NMDA receptor N2 subunits. The phosphorylated forms
of GluN2A and GluN2B, pTyr1246- and pTyr1325-GluN2A,
and pTyr1472-GluN2B were decreased in Pyk2 / compared
to wild-type mice. Total GluN2B was not changed indicating
deﬁcient tyrosine phosphorylation in the absence of Pyk2
(Fig. 2d,e). In contrast, total GluN2A was decreased (Fig. 2d,e).
We also examined PSD-95, a post-synaptic scaffolding protein
that interacts with both NMDA receptors and Pyk2 (refs 5,14).
The levels of PSD-95 were markedly decreased in homozygous
mutant mice (Fig. 2d,e). Thus, in contrast with the behavioural
and physiological deﬁcits, which appeared as pronounced in
heterozygous as in homozygous mutant mice (see Fig. 1), the
protein alterations in Pyk2þ / mice were intermediate between
wild type and Pyk2 / , indicating some proportionality
between the decrease in Pyk2 and its consequences on other
proteins. To determine the changes in receptors that took place at
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synapses, we carried out subcellular fractionation and isolated
postsynaptic densities (PSDs). The amounts of GluN1, GluN2A,
GluN2B and PSD-95 were decreased in the PSD fraction of
Pyk2 / mice as compared to wild type (Fig. 2e,f). These results
showed that the lack of Pyk2 signalling resulted in decreased
tyrosine phosphorylation of SFKs and GluN2B subunits as well as
decreased levels of GluN2A and PSD95 total protein. The
enrichment of all these proteins in PSDs was markedly decreased,
indicating a key role of Pyk2 in regulating the recruitment of
post-synaptic proteins to PSDs.
Spines are altered in the hippocampus of Pyk2 mutant mice.
To explore how Pyk2 deﬁcit could induce alterations of synaptic
proteins, we ﬁrst determined its localization in CA1. Pyk2
immunoﬂuorescence in the neuropil was punctate and appeared
to surround MAP2-positive dendritic processes (Fig. 3a). Some
Pyk2-positive puncta co-localized with PSD-95-positive puncta,
identifying them as PSDs (Fig. 3b). We then examined
Pyk2 immunoreactivity by electron microscopy. Pyk2-positive
immunogold particles were found in both presynaptic elements
and dendritic spines (Fig. 3c and Supplementary Fig. 3a). Pyk2
was enriched in asymmetric (presumably excitatory) synapses as
compared to symmetric (presumably inhibitory) synapses
(Supplementary Fig. 3a–d). Because of Pyk2 co-localization with
PSD-95 and of the marked decrease in PSD-95 in Pyk2 / mice,
we quantiﬁed PSD-95-positive puncta in CA1 stratum radiatum
of wild-type and mutant mice. The number of PSD-95-positive
puncta was signiﬁcantly reduced in Pyk2þ / and even more
so in Pyk2 / as compared to Pyk2þ /þ mice (Fig. 3d,e).
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Figure 1 | Spatial learning and memory and CA1 LTP deﬁcits in Pyk2 mutant mice. (a) In the spontaneous alternation test, Pyk2þ /þ , Pyk2þ / and
Pyk2 / 3-month-old mice were placed for 10min in a Y-maze with one arm closed (upper left panel). Two hours later, they were put in the same maze
with the new arm (NA) open and the percentage of time exploring the NA and the previously explored (old arm, OA) was compared (upper right panel).
Two-way ANOVA interaction F(2,48)¼ 11.6, Po0.0001, OA versus NA Holm-Sidak’s test, Pyk2þ /þ , t¼4.6, Po0.0001, Pyk2þ / , t¼ 1.58, Pyk2 / ,
t¼0.81. (b) In the NOL test, the percentage of time exploring the displaced object (new location, NL, 24 h after ﬁrst exposure) and the unmoved object
(old location, OL) was compared (upper panels). Two-way ANOVA interaction F(2,50)¼ 3.41, P¼0.041, OL versus NL Holm-Sidak’s test, Pyk2þ /þ , t¼ 3.1,
Po0.01, Pyk2þ / , t¼0.23, Pyk2 / , t¼0.14. In a,b, 7–12 mice were used per genotype; the red dotted line indicates the chance level. (c,d) Schaffer
collaterals were stimulated in hippocampal slices (one–three slices per animal) from 3-4-week-old Pyk2þ /þ (n¼ 5), Pyk2þ / (n¼6) and Pyk2 /
(n¼4) mice, and fEPSP were recorded in CA1, before and after HFS (5 1 s at 100Hz). (c) Time course of fEPSP slope. Insets show typical traces before
(grey) and 40min after (black) HFS in Pyk2þ /þ and Pyk2 / slices. (d) Ten-min average of fEPSP slope 40min after HFS, normalized to the mean of
10-min baseline (corresponding time points are indicated in c by grey and black horizontal lines). Kruskal–Wallis¼9.37, P¼0.0024, post hoc analysis
with Dunn’s multiple comparisons test. (e) Paired-pulse ratio (50-ms interval, see Supplementary Fig. 1e) at the same synapses. n¼ 3–5 mice per group,
two–four slices per mouse. Kruskal–Wallis¼ 15.62, P¼0.0004. In a–e, values are meansþ s.e.m., *Po0.05, **Po0.01, ***Po0.001.
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms15592 ARTICLE
NATURE COMMUNICATIONS | 8:15592 | DOI: 10.1038/ncomms15592 | www.nature.com/naturecommunications 3
This effect appeared consistent throughout CA1 depth (Supple-
mentary Fig. 3e).
To determine the consequences of these alterations on spines,
we analysed spine density and morphology in CA1 pyramidal
neurons, using the Golgi-Cox method (Fig. 3f). The apical
dendritic spines density was decreased in Pyk2þ / ( 8%) and
Pyk2 / ( 16%) mice as compared to wild type (Fig. 3g). The
decrease in spine number was less pronounced than the decrease
in PSD-95 puncta, possibly due to an immunoﬂuorescence
detection threshold and/or an increased number of spines lacking
PSD-95. To determine whether the absence of Pyk2 also affected
spine morphology, we quantiﬁed the spine head diameter and
spine neck length. Spine head size did not change between
genotypes (Fig. 3h), whereas spine neck length was decreased in
Pyk2 mutant mice (Fig. 3i). Altogether, these data show that the
lack of Pyk2 leads to a decrease in PSD-95 at synapses and a
decreased number of PSDs and spines.
Adult hippocampal Pyk2 deletion recapitulates the phenotype.
Although Pyk2 expression in the hippocampus is mostly post-
natal4, the severe alterations observed in Pyk2þ / and Pyk2 /
mice could result from developmental effects. To rule out this
possibility, we used 3-month-old mice bearing ﬂoxed Pyk2 alleles
(Pyk2f/f mice). Mice received a bilateral stereotaxic injection
in CA1 of adeno-associated virus expressing Cre recombinase
and GFP (AAV-Cre) or expressing GFP alone (AAV-GFP),
as a control (Fig. 4a). Three weeks after AAV-Cre injection,
Pyk2 expression disappeared in CA1, whereas the injection of
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Figure 2 | Hippocampal proteins phosphorylation and levels in Pyk2-deﬁcient mice. (a) Immunoblotting analysis of Pyk2, the related tyrosine kinase
FAK, the active autophosphorylated form of Src-family kinases (pY-SFK, pTyr-420 in Fyn), Fyn and tubulin as a loading control in 3-month-old Pyk2þ /þ ,
Pyk2þ / and Pyk2 / littermates. (b) Densitometry quantiﬁcation of results as in a. Data were normalized to tubulin for each sample and expressed as
percentage of wild type. (c) NMDA receptors subunits phosphorylated residues, total levels and PSD-95 were analysed by immunoblotting. (d) Results as
in c were quantiﬁed and analysed as indicated in b. In b and d, statistical analysis was done with one-way ANOVA and Holm-Sidak’s multiple comparisons
test or Kruskal–Wallis and Dunn’s test depending on the normality of distribution (see Supplementary Table 1 for tests used, values and number of mice).
(e) PSD fraction was prepared from hippocampus of Pyk2þ /þ and Pyk2 / mice and NMDA receptor subunits and PSD-95 were analysed in this
fraction by immunoblotting. (f) Quantiﬁcation of immunoblots as in e. Data are expressed as a percentage of the mean values in wild-type PSDs. Two-tailed
Mann and Whitney test (n¼ 7þ /þ and 5 / ): GluN1, t10¼ 3.52, P¼0.0056, GluN2A, t10¼ 2.68, P¼0.023, GluN2B, t10¼ 2.69, P¼0.022, PSD-95,
t10¼ 2.66, P¼0.024. In a,c,e, molecular weight markers positions are indicated in kDa. In b,d, Holm-Sidak’s versus wild type, *Po0.05, **Po0.01,
***Po0.001 and ****Po104; signiﬁcant differences between  / and  /þ are indicated with Po0.05, Po0.01 and Po104. In Dunn’s test
(d) and Mann and Whitney’s test (f), signiﬁcant differences versus wild type are indicated with # Po0.05, ### Po0.01 and #### Po104. In all graphs,
data are meansþ s.e.m. Uncropped blots for a,c and e are shown in Supplementary Figs 5, 6 and 7, respectively.
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AAV-GFP had no effect (Fig. 4a). In the NOL test, AAV-GFP-
injected mice showed increased preference for the object placed
at the new location, whereas AAV-Cre-injected mice did not
(Fig. 4b). We analysed spine density in CA1 apical dendrites and
found it was signiﬁcantly reduced in AAV-Cre-injected mice as
compared to AAV-GFP-injected mice (Fig. 4c,d). We also
quantiﬁed a reduced number of PSD-95-positive puncta in CA1
stratum radiatum of AAV-Cre-injected mice as compared to
AAV-GFP-injected mice (Fig. 4e,f). Altogether these results show
that local deletion of Pyk2 in CA1 of adult mice recapitulates
behavioural and morphological deﬁcits observed in Pyk2þ /
and Pyk2 / mice, ruling out a developmental effect in the
phenotype of Pyk2 mutant mice.
Pyk2 is needed for NMDA-induced PSD-95 recruitment in spines.
PSD-95 undergoes rapid activity-dependent relocalization24.
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Figure 3 | Pyk2 localization and dendritic spine density and morphology in Pyk2-deﬁcient mice. (a,b) Confocal microscopy images of CA1 stratum
radiatum immunostained for (a) Pyk2 (red) and MAP2 (green; inset, higher magniﬁcation of the indicated white box) and for (b) Pyk2 (green) and PSD-95
(red; white arrows, double-labelled puncta). Scale bars, 80mm (a) and 3 mm (b). (c) Electron microscopy in the same region showing of Pyk2
immunoreactive gold particles in a presynaptic terminal (arrow) and a PSD (arrowhead). Scale bar, 0.2mm. (d) Immunoﬂuorescence PSD-95-positive
puncta in the CA1 stratum radiatum from Pyk2þ /þ and Pyk2 / mice. Scale bar, 5 mm. (e) Quantiﬁcation of puncta as in d. Data are meansþ s.e.m.
(7–10 mice per genotype, three quantiﬁed sections per mouse). One-way ANOVA F(2,21)¼ 10.23, P¼0.0008. Holm-Sidak’s multiple comparisons test
versus þ /þ , **Po0.01, ***Po0.001. (f) Golgi-Cox-stained apical dendrites of CA1 stratum radiatum pyramidal neuron from Pyk2þ /þ , Pyk2þ / and
Pyk2 / mice. Scale bar, 3 mm. (g) Quantiﬁcation of spine density in dendrites as in f, three–four animals per genotype, one-way ANOVA, F(2,146)¼ 14.95,
Po104 (n¼47–54 dendrites per group), post hoc analysis with Holm-Sidak’s multiple comparisons test versus þ /þ , **Po0.01, ****Po104 and
 / versus  /þ , Po0.01. (h,i) Cumulative probability of spine head diameter (h, n¼80) and spine neck length (i, n¼ 115) in B60 dendrites
from three–four animals per genotype. Distributions were compared with the Kolmogorov–Smirnov test: spine head diameter no signiﬁcant difference,
neck length þ /þ versus þ / , D¼0.108, P¼0.04, þ /þ versus  / , D¼0.154, P¼0.0005. In e,g, data are meansþ s.e.m. All mice were
3–4-month old.
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Although neuronal stimulation decreases PSD-95 palmitoylation-
dependent synaptic targeting25 and increases its ubiquitination
and degradation26, prolonged neuronal activity was shown
to increase PSD-95 synaptic concentration27. PSD-95 is
phosphorylated on multiple tyrosine residues and this
phosphorylation can increase its synaptic clustering28,29. Since
PSD-95 synaptic clustering was decreased in the absence of Pyk2
(Figs 3d,e and 4e,f), we hypothesized Pyk2 may inﬂuence the
synaptic localization of PSD-95. We tested this hypothesis using
hippocampal neurons in primary culture at B21–22 DIV. As
expected, glutamate treatment (40 mM, 15min) increased Pyk2
phosphorylation at Tyr402 in hippocampal neurons in culture
and this effect was prevented by an NMDA receptor antagonist,
MK801 (10 mM, Fig. 5a,b). The size of PSD-95-positive puncta
measured 3 h after glutamate treatment was increased and
this effect was also prevented by MK801 (Fig. 5c,d). We then
compared the effects of glutamate on the size of PSD-95 puncta in
neurons from wild-type and Pyk2-KO mice (Fig. 5e,f). In the
absence of Pyk2, the effects of glutamate on the size of PSD-95
puncta were lost (Fig. 5e,f). Taken together, these results reveal a
role for Pyk2 in NMDA receptor-induced PSD-95 recruitment at
post-synaptic sites.
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Figure 4 | Pyk2 ablation in CA1 from adult mice induces spatial learning deﬁcits and spine alterations. (a) Mice with ﬂoxed Pyk2 alleles (Pyk2f/f, 4-
week-old) were bilaterally injected in dorsal hippocampus CA1 with AAVexpressing GFP (AAV-GFP) or GFP-Cre (AAV-Cre). GFP ﬂuorescence (green) and
Pyk2 immunoreactivity (red) were detected with confocal microscope (stitched pictures). With both viruses widespread, GFP expression is present in CA1
and Pyk2 is reduced in CA1 of AAV-Cre-injected mice. Scale bar, 200mm. (b) AAV-GFP and AAV-Cre mice were subjected to the NOL test as in Fig. 1b and
the percentage of time exploring the displaced object (NL) compared to that exploring the unmoved object (OL). Two-way ANOVA interaction
F(1,44)¼ 9.94, P¼0.003, OL versus NL Holm-Sidak’s test, AAV-GFP, t¼4.0, Po0.001, AAV-Cre, t¼0.45, ns (12 mice per group). The red dotted line
indicates the chance level. (c) Representative Golgi-Cox-stained apical dendrites from CA1 pyramidal neurons of AAV-GFP and AAV-Cre mice. Scale bar,
4mm. (d) Quantiﬁcation of spine density in dendrites stained as in c, 81–86 dendrites from four mice per genotype. Student’s t-test t165¼ 10.1, Po104.
(e) PSD-95 immunoreactive puncta in CA1 stratum radiatum of AAV-GFP and AAV-Cre mice. Scale bar, 4mm (c,e). (f) Quantiﬁcation of PSD-95-positive
puncta density as in e, three sections per mouse, six–eight mice per genotype, Student’s t-test t12¼ 2.36, Po0.5. In a,d,f, data are meansþ s.e.m.,
*Po0.05, ***Po0.001 and ****Po104.
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Pyk2 function in spines is partly phosphorylation dependent.
Since Pyk2 is a large protein that has tyrosine kinase activity,
including functionally important autophosphorylation activity,
and interactions with multiple partners9, we examined which of
its molecular properties were required for regulation of PSD-95
and spines. We transfected wild-type and Pyk2-KO hippocampal
cultures with GFP or GFP fused to either Pyk2, or Pyk21–840,
unable to bind to PSD-95 (ref. 5), or Pyk2Y402F with a point
mutation of the autophosphorylation site or to kinase-dead Pyk2
(Pyk2-KD) with a K457A mutation30. We ﬁrst analysed the size
of PSD-95-positive puncta in these various conditions (Fig. 6a).
As in untransfected neurons (see Fig. 5c–f), glutamate treatment
increased the size of PSD-95-positive puncta in wild-type cultures
transfected with either GFP or GFP:Pyk2, used as controls
(Fig. 6a,b). Glutamate effects were absent in KO cultures trans-
fected with GFP, but were rescued by Pyk2:GFP transfection
(Fig. 6a,b). In contrast, glutamate treatment did not increase
PSD-95-positive puncta size in Pyk2 / cultures transfected
with GFP:Pyk21–840, GFP:Pyk2Y402F or GFP:Pyk2-KD (Fig. 6a,b).
These results show that the autophosphorylation site, Tyr-402,
the kinase activity and the C-terminal domain of Pyk2 are all
essential for glutamate-induced PSD-95 synaptic translocation.
We then examined if the spine density could be rescued
in cultured hippocampal neurons. Dendritic spine density was
reduced in Pyk2-KO neurons as compared to wild type
(Fig. 6c,d), as observed in vivo (Fig. 3f,g). Transfection of
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Figure 5 | Pyk2 modulates glutamate-induced PSD-95 accumulation in dendritic spines. (a) Hippocampal neurons were cultured for 3 weeks and treated
for 15min with vehicle or glutamate (Glu, 40mM) without or with MK801 (MK, 10 mM), added 30min before. PhosphoTyr402-Pyk2 (pY402-Pyk2),
Pyk2 and a-tubulin as a loading control were analysed by immunoblotting. Molecular weight markers position is indicated in kDa. (b) Densitometric
quantiﬁcation of results as in a. One-way ANOVA (F(2,13)¼ 8.02, P¼0.005, n¼4–7 per group) and post hoc Holm-Sidak’s test for multiple comparisons.
(c) Cultured hippocampal neurons were treated with vehicle or glutamate (40 mM) without or with MK801 (10 mM) for 3 h, ﬁxed and labelled for PSD-95
immunoreactivity and rhodamine–phalloidin (an F-actin marker) to identify PSD-95-positive puncta localized in dendritic spines (arrows). (d) The size of
these PSD-95-positive puncta was measured and analysed with one-way ANOVA (F(2,30)¼ 15.37, Po0.0001, n¼ 10–12 per group) and Holm-Sidak’s test.
(e) Hippocampal neurons from wild-type (WT) or Pyk2 KO mice were treated for 3 h with vehicle (Veh) or glutamate (40 mM) and immunostained for
PSD-95. (f) The size of spine-associated PSD-95-positive puncta was measured in Pyk2þ /þ and Pyk2 / hippocampal cultures treated as in e and
quantiﬁed (n¼ 18–27 per group). Statistical analysis with two-way ANOVA (interaction F(1,89)¼ 12.42, P¼0.0007, glutamate effect, F(1,89)¼ 1.84, P¼0.18,
genotype effect, F(1,89)¼ 35.29, Po104) and post hoc multiple comparisons Holm-Sidak’s test. In d,f, one–two dendrites per neuron from two to three
independent experiments were measured. In b,d,f, data are meansþ s.e.m., *Po0.05, **Po0.01, ***Po0.001, as compared to vehicle-treated Pyk2þ /þ
cultures; Po0.05, Po0.001 and Po104, as compared to glutamate-treated Pyk2þ /þ cultures. Scale bars, 5 mm (c and e). Uncropped blots for a
are shown in Supplementary Fig. 8.
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GFP:Pyk2 rescued spine density in KO neurons in vitro
(Fig. 6c,d). Transfection of GFP:Pyk21–840 had no signiﬁcant
effect, but, in contrast to what we observed for PSD-95 puncta
rescue (see Fig. 6b), both GFP:Pyk2Y402F and GFP:Pyk2-KD fully
restored spine density (Fig. 6c,d), revealing a role for Pyk2
independent of its autophosphorylation and kinase activity.
We also quantiﬁed the effects of Pyk2 deletion on spine length
(Fig. 6e). In the absence of Pyk2, spines were shorter, as observed
in vivo (see Fig. 3i), but this effect was not rescued by re-
expression of wild type or mutated Pyk2 (Fig. 6e). This lack of
rescue of spine length deﬁcits in vitro may indicate a contribution
of presynaptic Pyk2 in spine length regulation since with the low
transfection rate in our culture system, concomitant transfection
of pre- and post-synaptic neurons was very rare. Taken together,
these results show that Pyk2 is important for PSD-95 synaptic
enrichment and that this function requires both the C-terminal
region involved in PSD-95 interaction and the autophosphoryla-
tion site and tyrosine kinase activity. In contrast, Tyr402 or kinase
activity is not necessary for Pyk2 effects on spine density,
revealing the existence of autophosphorylation/kinase activity-
dependent and -independent roles of Pyk2 in spines.
Hippocampal Pyk2 is altered in HD. Since our results empha-
sized the high sensitivity of hippocampal function to Pyk2 protein
Ve
hi
cl
e
G
lu
ta
m
at
e
PS
D-
95
/G
FP
GFP GFPPyk2
Pyk2 Pyk2(Y402F)Pyk2(1–840)
WT WT KO
KO KOKO
WT KOWT KO
KO KO
GFP Pyk2 GFP Pyk2
Pyk2(1–840) Pyk2(Y402F)
Sp
in
e 
de
ns
ity
 (s
pin
es
 µm
–
1 )
WT KO
G
lu
ta
m
at
e
PS
D-
95
/G
FP V
eh
ic
le
0.0
0.5
1.0
1.5
2.0
2.5
1–
84
0
Y4
02
F
GF
P
Py
k2GF
P
Py
k2
*** ***
***
***
PS
D-
95
-p
os
itiv
e 
pu
nc
ta
 s
ize
 ( µ
m
2 )
+/– Glutamate 40 µM
0.00
0.05
0.10
0.15
+–+–+–+– +–+–
**** **** ****
+–
WT
1–840Pyk2 Y402F
KO
GFP Pyk2GFP KD
0.0
0.5
1.0
1.5
2.0 ***
Sp
in
e 
le
ng
th
 (µ
m
)
KD
WT KO
1–
84
0
Y4
02
F
GF
P
Py
k2GF
P
Py
k2 KD
KO
Pyk2(KD)
KO
Pyk2(KD)
a
b
c
d e
Figure 6 | Autophosphorylation-dependent and -independent roles of Pyk2 in dendritic spines. (a) Hippocampal neurons from wild-type (WT) and Pyk2
KO mice were cultured for 21–22 days, transfected with plasmids coding GFP or GFP fused to wild-type Pyk2, to Pyk2(1-840), Pyk2(Y402F) or Pyk2-KD
(as indicated), and treated with vehicle or glutamate (Glu, 40mM, 3 h). Neurons were imaged for GFP ﬂuorescence (green) and PSD-95 immunoreactivity
(red). (b) Quantiﬁcation of GFP/PSD-95 double-positive puncta size (that is, yellow puncta) as in a. Two-way ANOVA: interaction, F(6,312)¼ 19.07,
Po104, glutamate effect, F(1,312)¼ 134.3, Po104, Pyk2 expression effect, F(6,312)¼ 20.06, Po104. (c) Spine density and length were studied in similar
conditions as in a, in the absence of treatment, using GFP or Pyk2:GFP ﬂuorescence. (d) Quantiﬁcation of spine density. One-way ANOVA: F(6,155)¼ 24.90,
Po104. (e) Quantiﬁcation of spine length. One-way ANOVA: F(6,157)¼ 30.68, Po104 and. In b,d,e, individual data points and meansþ s.e.m. are
shown, 15–20 dendrites per condition (one–two dendrites per neuron) from two to three independent experiments. Post hoc multiple comparisons were
done with Holm-Sidak’s test (b,d,e), ***Po0.001, ****Po104. Scale bars, 3mm (a) and 1mm (c).
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expression levels, we hypothesized that any alteration in
Pyk2 levels in pathological conditions might have deleterious
consequences. HD appeared as an interesting condition since
Pyk2 and wild-type Htt interact with the same SH3 domain of
PSD-95 (refs 14,31). This interaction is altered in mutant Htt with
a pathological polyglutamine expansion31, resulting in PSD-95
mislocalization to extrasynaptic sites32. We noticed that the
hippocampal phenotype of Pyk2 KO mice resembled that of HD
mouse models, which display spatial learning impairments33,
decreased PSD-95 (ref. 34), dendritic spines loss35 and shorter
dendritic spine necks33. To test the possible involvement of Pyk2
in HD, we ﬁrst measured Pyk2 protein levels in post-mortem
hippocampal samples from human patients. In patients with
intermediate or late HD (grades 3–4 (ref. 36)) Pyk2 levels were
reduced to 64±8% of controls (mean±s.e.m., Fig. 7a,b), whereas
in patients at prodromal or early stage (grades 1–2) there was no
signiﬁcant change (Supplementary Fig. 4a,b). Pyk2 was also
diminished in the hippocampus of R6/1 mice, an HD mouse
model, transgenic for the ﬁrst exon of the human Htt gene
with ampliﬁed CAG repeats37 (64±6% of control levels,
mean±s.e.m., Fig. 7a,c). Since Pyk2 can trafﬁc between
cytoplasm and nucleus38, and since R6/1-mutated Htt
accumulates in the nucleus39 we looked for the existence
of altered cytonuclear distribution of Pyk2 or its possible
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sequestration in nuclear aggregates. Although Pyk2 was
predominantly decreased in the cytoplasm (Supplementary
Fig. 4c,d) it was not sequestered in intra-nuclear aggregates
and did not co-localize with EM48-immunolabelled nuclear
aggregates (Supplementary Fig. 4e). These results indicated a
reduced Pyk2 function in the cytoplasm of HD mice. Indeed,
in R6/1 mice we observed changes similar to those in Pyk2
mutant mice, including a decrease in total GluN2A but no change
in GluN2B, a decrease in tyrosine phosphorylated GluN2A and
GluN2B, and a marked decrease in total PSD-95 (Fig. 7d,e).
Double immunostaining for Pyk2 and PSD-95 in CA1 of
wild-type and R6/1 mice showed a decreased number of
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PSD-95-positive puncta in R6/1 mice as compared to wild-type
mice (Fig. 7f,g), and less co-localization of PSD-95-positive and
Pyk2-positive puncta in mutant mice (Fig. 7h). The similarity in
the modiﬁcations observed in R6/1 mice and Pyk2 mutant mice
suggested that the decreased levels of Pyk2 might contribute to
PSD-95 and NMDA receptors subunits alterations.
Pyk2 partly rescues the hippocampal phenotype of R6/1 mice.
Since the levels of Pyk2 in the hippocampus of HD patients and
R6/1 mice (Fig. 7a–c) were close to those in Pyk2þ / mice,
which displayed a similar phenotype, we asked whether correct-
ing this defect in R6/1 mice could rescue some of their deﬁcits.
We stereotaxically injected AAV expressing either Pyk2 and GFP
or GFP alone in the dorsal hippocampus of R6/1 mice (R6/1-Pyk2
and R6/1-GFP mice, respectively) or GFP alone in wild-type mice
(WT-GFP) as a control. Three weeks after the injection, GFP
expression demonstrated a wide spreading of viral transduction
within the dorsal hippocampus, but restricted to this brain
structure (Supplementary Fig. 4f). Immunoblotting showed that
Pyk2 levels in R6/1-GFP mice, which were 50±3% of those in
WT-GFP mice, were raised to 80±4% in R6/1-Pyk2 mice
(Fig. 8a,b). The recovery of Pyk2 expression restored R6/1 mice
performance in the Y-maze spontaneous alternation task (Fig. 8c)
and corrected the deﬁcit in the novel object recognition task
(Fig. 8d). We also examined LTP in these mice at the same age as
for behavioural experiments (4–5 months). In WT-GFP mice,
we observed a robust LTP in CA1 after stimulation of Schaffer
collaterals (Fig. 8e,f). In contrast, in R6/1-GFP and R6/1-Pyk2
mice, synaptic potentiation was not stable (Fig. 8e,f). One
hour after high frequency stimulation (HFS), potentiation was
observed only in WT-GFP mice (Fig. 8f), revealing that
restoration of Pyk2 levels was not sufﬁcient to correct the LTP
impairment.
To assess the cellular effects of Pyk2 recovery possibly
underlying the behavioural improvements, we analysed spine
density in CA1 apical dendrites by the Golgi-Cox method
(Fig. 8g). Spine density, which was decreased in R6/1-GFP
compared to WT-GFP mice, was partly restored by Pyk2 viral
expression in R6/1-Pyk2 mice (Fig. 8g,h). We also analysed
PSD-95- and Pyk2-positive puncta in CA1 stratum radiatum of
the three groups of mice (Fig. 8i). R6/1-GFP mice displayed a
reduced number of PSD-95-positive puncta (Fig. 8j) and fewer
double-positive PSD-95/Pyk2 puncta (Fig. 8k) compared to
WT-GFP mice, consistent with the results shown in Fig. 7g–i.
The numbers of PSD-95-positive puncta (Fig. 8j) and
PSD-95/Pyk2 double-positive puncta (Fig. 8k) were both
completely rescued in R6/1-Pyk2, reaching values similar to
those in WT-GFP mice. These results strongly indicate that Pyk2
deﬁcit contributes to the hippocampal phenotype of the R6/1 HD
mouse model, including cognitive deﬁcits, dendritic spine loss
and PSD-95 alteration. Moreover, they show that these deﬁcits
can be improved by Pyk2-induced expression, although this
expression was not sufﬁcient to restore synaptic plasticity in our
experimental conditions.
Discussion
Here we show the functional importance of the Ca2þ -activated
non-receptor tyrosine kinase Pyk2 for hippocampal function and
spines physiology. We also provide evidence that Pyk2 deﬁcit
contributes to the hippocampal impairments in a mouse model
of HD, a severe genetic neurodegenerative disorder. Although
Pyk2þ / and Pyk2 / mice develop and breed normally in
standard animal facility conditions, and show no gross beha-
vioural defects, they appear strongly deﬁcient in hippocampal-
related memory tasks. These behavioural impairments were
accompanied by impaired synaptic plasticity, decreased levels
and/or tyrosine phosphorylation of NMDA receptor subunits,
and alterations in PSDs composition and in spines density and
morphology.
A previous study in hippocampal slices using overexpression or
interfering constructs, reported that Pyk2 can regulate NMDA
receptor function and LTP induction7. Here we show that in Pyk2
mutant mice LTP was not induced in standard conditions at
Schaffer collaterals synapses on CA1 pyramidal neurons.
A number of biochemical alterations at the post-synaptic level
are likely to participate in this deﬁcit. Both GluN2A and GluN2B
were altered with a decreased total and tyrosine phosphorylated
GluN2A and a decreased tyrosine phosphorylation of GluN2B.
Moreover, subcellular fractionation revealed a decrease in the
three NMDA receptor subunits (GluN1, GluN2A and GluN2B)
in the PSD fraction. The reduction of GluN2B in PSDs may
result from its decreased tyrosine phosphorylation, which is
known to promote surface expression of GluN2B-containing
NMDA receptors and their recruitment to PSDs40,41. This
phosphorylation deﬁcit was in agreement with the decreased
active form of SFKs we observed in Pyk2 mutant mice,
supporting their role in mediating NMDA receptors
phosphorylation downstream from Pyk2 (ref. 7). In the case of
GluN2A, the total protein and the phosphorylated form
were decreased. Since tyrosine phosphorylation of GluN2A
increases NMDA receptor currents42,43, reduction of both
forms of GluN2A may contribute to synaptic defects of Pyk2
knockout mice. These alterations seemed to be speciﬁc for the
NMDA receptor complex since AMPA receptors levels and
phosphorylation were not affected. These combined alterations in
NMDA receptor subunits provide a ﬁrst basis for the functional
deﬁcit in LTP induction. Many other aspects of synaptic function
and plasticity remain to be investigated in Pyk2 mutant mice, and
Figure 8 | Pyk2 protein levels restoration in the hippocampus partly rescues R6/1 mice phenotype. (a) Pyk2 and a-tubulin (loading control)
immunoblotting in 3-month WTmice injected with AAV-GFP (WT-GFP), or R6/A injected with AAV-GFP (R6/1-GFP) or AAV-Pyk2 and GFP (R6/1-Pyk2).
Uncropped blots in Supplementary Fig. 11. (b) Quantiﬁcation of results as in a (six–nine mice per group). One-way ANOVA: F(2,18)¼4.39, Po0.05,
Holm-Sidak’s test versus R6/1-GFP. (c) Y-maze spontaneous alternation test (10–11 mice per group). Two-way ANOVA interaction F(2,56)¼4.39, Po0.05,
OA versus NA, Holm-Sidak’s test WT-GFP t¼ 2.64, Po0.05, R6/1-GFP, t¼0.97, ns, R6/1-Pyk2, t¼ 2.93, Po0.05. (d) NOL test (9–12 mice per group).
Two-way ANOVA interaction F(2,54)¼ 11.9, Po0.0001, OL versus NL, Holm-Sidak’s test WT-GFP t¼9.08, Po0.0001, R6/1-GFP, t¼ 1.60, ns, R6/1-Pyk2,
t¼ 6.66, Po0.0001. (e) LTP studied as in Fig. 1c in hippocampal slices from 5-month WT-GFP, R6/1-GFP and R6/1-Pyk2 mice (n¼ 3–4 mice per group,
2–3 slices per mouse, 10–11 slices total). (f) Ten-min average of fEPSP slope 40min after HFS, normalized to the mean of 10-min baseline (corresponding
time points are indicated in e by an horizontal line). Kruskal–Wallis¼ 15.63, Po0.05, post hoc analysis with Dunn’s multiple comparisons test.
(g) Golgi-Cox-stained apical dendrites from CA1 pyramidal neurons. Scale bar, 3 mm. (h) Quantitative analysis of dendritic spine density as in e (59–62
dendrites from four mice per group). One-way ANOVA: F(2,177)¼46.7, Po104, Holm-Sidak’s test versus R6/1-GFP. (i) Hippocampal sections of WTand
R6/1 mice injected with AAV-GFP or AAV-Pyk2 as indicated, and double-immunostained for PSD-95 and Pyk2. High magniﬁcation in CA1 stratum radiatum
is shown. Scale bar, 5mm. (j) Quantiﬁcation of PSD-95-positive puncta density. One-way ANOVA F(2,14)¼ 10.81, P¼0.0014, Holm-Sidak’s multiple
comparisons test. (k) Quantiﬁcation of PSD-95/Pyk2 double-positive puncta density. One-way ANOVA F(2,14)¼9.76, P¼0.0022, Holm-Sidak’s multiple
comparisons test. In j,k, ﬁve–seven mice per group. In all graphs values are meansþ s.e.m. *Po0.05, **Po0.01, ***Po0.001 and ****Po104.
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the modiﬁcations induced by the absence of Pyk2 clearly extend
beyond NMDA receptors.
A marked alteration observed in Pyk2 mutant mice concerned
PSD-95. PSD-95 SH3 domain is known to bind Pyk2 C-terminal
Pro-rich motif14, thereby clustering and activating Pyk2 in
response to Ca2þ increase5,14. In contrast, effects of Pyk2 on
PSD-95 have not been described. Our study reveals that Pyk2 has
a critical inﬂuence on PSD-95, regulating its levels, its localization
at PSDs in basal conditions and its clustering in response
to stimulation of NMDA receptors. The decreased PSD-95
expression cannot explain, by itself, the absence of LTP in Pyk2
mutant mice, since PSD-95 knockout mice display an enhanced
LTP44. Therefore, the functional deﬁcit is likely to result from its
combination with dysregulation of NMDA receptors and possibly
other proteins. PSD-95 is phosphorylated by c-Abl and SFKs on
several tyrosine residues, which can favour PSD-95 aggregation
and GluN2A activation28,45. Thus, there appears to be a
reciprocal interaction between Pyk2 and PSD-95, each
enhancing the function of the other, thereby directly and
indirectly regulating NMDA receptors and PSD organization.
In support of this functional association, it has been reported
that in hippocampal neurons in culture, corticosterone-induced
recruitment of Pyk2, PSD-95 and GluN1 to spines requires Pyk2
activation46. NMDA receptor activation recruits Pyk2 to spines
through its interaction with PSD-95 (ref. 5), whereas it also
rapidly destabilizes PSD-95 and removes it from PSDs47. Our
study shows that Pyk2 is required for the later recruitment of
PSD-95 to spines revealing its contribution in the coordinated
Ca2þ -dependent dynamics of PSD proteins, a key aspect of
synaptic function and plasticity. Importantly, GluN2A, GluN2B
and PSD-95 co-assemble together with PSD-93 into 1.5MDa
‘supercomplexes’48. PSD-93 is phosphorylated by Fyn49, which is
altered in PyK2 mutant mice. Since both PSD-93 and PSD-95
promote Fyn-mediated tyrosine phosphorylation of GluN2A
and/or GluN2B50,51, it appears that Pyk2 is potentially placed at a
strategic location to regulate NMDA receptor supercomplexes.
Since these supercomplexes have been proposed to be
functionally important, with mutations in their key components
resulting in abnormal LTP and learning48, it will be particularly
interesting to investigate whether their alteration accounts for
LTP and other synaptic deﬁcits in Pyk2 mutant mice.
Dendritic spine density and length were also altered in Pyk2
mutant mice. Our study of the requirement of Pyk2 protein
domains and functions for its various roles reveals the complexity
of its contribution. The kinase activity of Pyk2 and its
autophosphorylation site, Tyr402, which is critical for the
recruitment of SFKs, were both necessary for the rescue of
PSD-95 clustering in spines in Pyk2 KO neurons. The C-terminal
region, which allows interaction with PSD-95 (ref. 14), was also
required for PSD-95 clustering. In contrast, rescue of spine
density required the C-terminal region but neither Tyr402 nor
the kinase activity, indicating a phosphorylation-independent
role of Pyk2 in the regulation of spine number. Such an
autophosphorylation/kinase activity-independent function of
Pyk2 is reminiscent of those reported for the closely related
FAK52,53 in non-neuronal cells. This alternate signalling is
presumably SFK-independent and may be linked to scaffolding
properties of Pyk2 and/or its interaction with speciﬁc partners.
The current study also suggests a role for Pyk2 at the
presynaptic level. Our electron microscopy experiments show the
presence of Pyk2 in nerve terminals, conﬁrming previous
biochemical observations54. Its functional role is indicated by
the alteration in paired-pulse facilitation, a form of short-term
plasticity that is considered to be mostly presynaptic55,56,
although post-synaptic mechanisms are also possible57. Finally,
in the absence of Pyk2, spine length was decreased both in vivo
and in culture. A possible explanation for this lack of rescue could
be a dual role of Pyk2 at the pre- and post-synaptic levels, which
were not simultaneously restored at the same synapses in the
culture conditions in which the transfection rate was low. At
any rate, the mechanisms by which Pyk2 controls spine length
are likely to be complex since both positive and negative effects
of Pyk2 and FAK on spine growth have been previously
reported58–60 and their elucidation will require further
investigation. The important aspect of the present results is the
overall deﬁcit in spine number and length in the absence of Pyk2.
Interestingly, it has been shown that chronic stress induces a
redistribution of activated Pyk2 to the perinuclear region of CA3
neurons, contributing to a deﬁcit in the nuclear pore protein
NUP62 and its potential negative consequences on dendritic
complexity61. The present study suggests that Pyk2 redistribution
could also directly contribute to dendritic or synaptic alterations
by reducing its local levels.
Our observations thus reveal an essential and complex role of
Pyk2 in the regulation of spines, PSDs and NMDA receptors,
whose alterations impair synaptic plasticity and hippocampal-
dependent memory in Pyk2-deﬁcient mice. The importance of
Pyk2 expression levels is underlined by the unexpected severity of
the functional deﬁcits in heterozygous mutant mice. Their
behavioural and physiological phenotype was as severe as in
homozygous mutant mice, whereas a clear gene dosage effect was
observed at the molecular level. This suggests that Pyk2
expression levels are a limiting factor for excitatory synapses
function in hippocampus and raises the question of the possible
implications of decreased Pyk2 protein levels in pathological
conditions. This hypothesis was supported by our results in a
mouse model of HD. Pyk2 was decreased in the R6/1 mouse, to a
level comparable to that observed in Pyk2þ / heterozygous
mutant mice, which displayed a clear behavioural phenotype.
Several alterations in R6/1 mice were similar to those in Pyk2
mutant mice including the alterations in NMDA receptors,
PSD-95 distribution and spines. Of course, such alterations could
potentially result from different mechanisms in the two types of
mutant mice, but our results provide strong evidence that Pyk2
deﬁcit contributes to some of the abnormalities observed in R6/1
mice. Although enhancing Pyk2 expression by AAV transduction
in R6/1 mice was not sufﬁcient to restore a normal LTP in CA1,
it corrected several behavioural, molecular and cellular deﬁcits.
Interestingly, the deleterious consequences of Pyk2 deﬁcit are
likely to synergize with other factors including increased activity
of STEP62, a tyrosine phosphatase active on Pyk2 (ref. 63),
which is expected to aggravate the functional consequences of
Pyk2 insufﬁciency. In patients, the role of Pyk2 deﬁciency
remains to be determined since it was detected in grades 3–4
when there is a loss of other synaptic proteins but not at earlier
stages (grades 1–2). Nevertheless, our results suggest that
strategies for enhancing Pyk2 expression or activity, or for
inhibiting STEP phosphatase activity64 could have a potential
therapeutic interest in HD. Further work will determine whether
Pyk2 deﬁciency could play a role in other neurodegenerative
conditions, such as Alzheimer disease8, besides its possible role as
modulator of Tau toxicity65.
Our study reveals that the absence of Pyk2 impairs synaptic
functions and hippocampal-dependent learning and memory. We
show that Pyk2 plays critical roles in spines and PSD organization
and in the regulation of PSD-95 and NMDA receptors. Although
we focused our investigations on hippocampus where Pyk2
expression is the highest, it is likely that it is also important
in other neurons, especially in neocortical areas where it is
highly expressed and which are known to undergo intense
synaptic plasticity. We also reveal the contribution of Pyk2 in
hippocampal dysfunction in a HD model and its potential
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reversibility. Our results should stimulate research on the role of
Pyk2 in other pathological conditions in which NMDA receptor
dysfunction is thought to be directly or indirectly involved.
Methods
Animals. For Pyk2 deletion, Pyk2f/f C57Bl/6 mice were generated in which the
PTK2B exons 15b-18 were ﬂanked with LoxP sequences (Gen-O-way, Lyon,
France) leading to a deletion that disrupts the protein kinase domain when crossed
with a expressing Cre line20. Pyk2 / mice and Pyk2f/f mice were genotyped
from a tail biopsy (Charles River, Saint-Germain-Nuelles, France) using for DNA
ampliﬁcation of ﬂoxed PTK2B as forward primer 50-GAGAGTGCTGGGT
ACTCCAGACTCAGATAG-30 and as reverse primer 50-TTCAGGAACACCAG
AGAACTAGGGTGG-30 and previously reported primers20 for Pyk2 / mice.
Heterozygous mice were crossed to generate þ /þ , þ / and  / mice. Male
R6/1 transgenic mice37 (4–5-month-old) expressing exon-1 mutant Htt with 145
glutamines under the HD human promoter and their wild-type littermates were
obtained from Jackson Laboratory (Bar Harbor, ME, USA). Housing room was
kept at 19–22 C and 40–60% humidity, under a 12:12 h light/dark cycle and
mice had ad libitum access to food and water. Animal experiments and handling
was in accordance with ethical guidelines of Declaration of Helsinki and NIH,
(1985-revised publication no. 85-23, European Community Guidelines), and
French Agriculture and Forestry Ministry guidelines for handling animals (decree
87849, licence A 75-05-22) and approval of the Charles Darwin ethical committee.
All mice used in this study were males and the ages are indicated in the ﬁgure
legends.
Behavioural phenotyping. Wire hanging, plus maze and open-ﬁeld paradigms
were carried out as described elsewhere66. In brief, for wire hanging, mice were
placed on a standard wire cage lid, which was then turned upside down for 60 s and
the number of falls was recorded. The elevated plus maze consisted of two
opposing 30 8 cm open arms, and two opposing 30 8 cm arms enclosed by
15 cm high walls. The maze was raised 50 cm from the ﬂoor and lit with dim light.
Each mouse was placed in the central square, facing an open arm and the time
spent in the open arms was recorded for 5min. The open ﬁeld apparatus was a
dimly lit white circular arena (40 cm diameter, 40 cm high wall). Mice were placed
in the arena centre and free exploration was recorded for 10min. NOL test and
spontaneous alternation in a Y-maze task (Y-SAT) were performed as previously
described33. Brieﬂy, for NOL an open-top arena (45 45 45 cm) was used. Mice
were ﬁrst habituated to the arena (2 days, 15min per day). On day 3 of the
acquisition phase, two identical objects (A1 and A2) were placed in the arena and
explored for 10min. Twenty-four hour later, one object was moved from its
original location to the diagonally opposite corner and mice were allowed to
explore the arena for 5min. The object preference was measured as the time
exploring each object 100/time exploring both objects. For Y-SAT, a Y-maze
apparatus, made of clear Perspex, was used (Y-maze dimensions: arms, 35 cm
length, 25 cm height, 15 cm width). For the training session, mice were placed in
the stem arm of the Y and allowed to explore for 10min only one accessible arm
(familiar arm) for 10min. They were then returned to their home cage. After an
inter-trial interval of 2 h, mice were placed in the stem arm of the T-maze and
allowed to freely explore all three arms for 5min. Big and highly perceptible objects
were situated surrounding the maze at 20–40 cm. The arm preference was
measured as the time exploring each arm 100/time exploring both arms. Animals
were tracked and recorded with Smart junior software (Panlab).
Viral constructs and stereotaxic injection. For speciﬁc deletion of Pyk2 in
dorsal hippocampus expression, 4-week-old Pyk2f/f mice were stereotaxically
injected with AAV expressing Cre recombinase and (AV-9-PV2521,
AAV9.CamKII.HI.eGFP-Cre.WPRE.SV40 (AAV-Cre)) (from Perelman School of
Medicine, University of Pennsylvania, USA). To overexpress Pyk2, we used
AAV1-CamKIIa0.4-GFP-2A-mPTK2B (AAV-Pyk2) with a T2A cleavable link
(Vector Biolabs Malvern, PA, USA). As a control, we injected AAVs expressing
GFP (AV-9-PV1917, AAV9.CamKII0.4.eGFP.WPRE.rBG (AAV-GFP) from
Perelman). Following anaesthesia with pentobarbital (30mg kg 1), we performed
bilateral injections of AAV-GFP, AAV-Cre or AAV-Pyk2 (2.6 109 GS per
injection) in the dorsal hippocampus following coordinates from the bregma
(millimetres); anteroposterior, –2.0; lateral, ±1.5; and dorsoventral, ±0.8. For
R6/1 mice, we performed an additional injection at dorsoventral ±1.2. AAV
injection was carried out in 2min. The cannula was left in place for 5min for
complete virus diffusion before being slowly pulled out of the tissue. After 2 h of
careful monitoring, mice were returned to their home cage for 3 weeks before
starting analyses of behaviour, biochemistry and morphology.
Electrophysiology. Littermate mice (1–2 months) received an injection of
ketamine/xylazine (75/10mg kg 1, i.p.) and intracardially perfused with an
ice-cold solution ((all mM) 25 NaHCO3, 1.25 NaH2PO4, 2.5 KCl, 0.5 CaCl2,
7 MgCl2, 110 choline chloride, 25 glucose, 11.6 ascorbic acid, and 3.1 pyruvic acid).
The brain was rapidly removed and horizontal slices (350 mm thick) cut with a
vibratome (Microm, Thermo Fisher). Slices were placed in an interface chamber
containing artiﬁcial CSF (ACSF) ((all mM) 124 NaCl, 1 NaH2PO4, 26.2 NaHCO3,
2.5 KCl, 1.6 CaCl2, 1.2 MgCl2, 11 glucose) at 37 C, saturated with 5% (vol/vol)
CO2 in O2, and allowed to recover for 1 h. Slices were then transferred to a
submerged recording chamber, a cut was made between the CA3 and CA1, and
bicuculline-supplemented ACSF used for superfusion. An ACSF-ﬁlled recording
borosilicate glass pipette (2–4MO) was inserted in the stratum radiatum of CA1
region. Schaffer collaterals were stimulated (HFS, 5 1 s at 100Hz) with a tungsten
bipolar electrode (0.5MO). Field excitatory post-synaptic potentials (fEPSPs) were
recorded using a multiclamp 700B ampliﬁer (Molecular Devices) low-pass ﬁltered
at 5 kHz and digitized at 20 kHz. Ofﬂine analysis of fEPSP slopes was done with
Clampﬁt software (Molecular Devices). Baseline potential was set to zero and
recordings were low-pass ﬁltered at 1 kHz with Bessel ﬁlter. A 1-ms time-window
was manually positioned at the onset of the fEPSP and its initial slope
automatically measured. LTP was investigated in AAV-injected R6/1 mice in
similar conditions except that mice were 5-month old at the time of the recording.
Paired pulse ratio was determined at a 50ms interval. In all cases, the experimenter
carrying out the acquisition and analysis of electrophysiological data was blind to
the mice genotype and/or AAV type.
Electronic microscopy. Mice were transcardially perfused with a solution
containing 40 g l 1 paraformaldehyde and 1ml l 1 glutaraldehyde in 0.1M
sodium phosphate buffer (PB), pH 7.4. Brains were then immersed in the same
ﬁxative 12 h at 4 C. Tissue blocks containing the hippocampus were dissected and
washed in 0.1M PB, cryoprotected in 10 and 20% sucrose in 0.1M PB, freeze
thawed in isopentane and liquid nitrogen. Samples were post ﬁxed in 25ml l 1
glutaraldehyde in 0.1M PB for 20min, washed and treated with 20 g l 1 osmium
tetroxide in PB for 20min. They were dehydrated in a series of ethanol and
ﬂat embedded in epoxy resin (EPON 812 Polysciences). After polymerization,
blocks from the CA1 region were cut at 70 nm thickness using an ultramicrotome
(Ultracut E Leica). Sections were cut with a diamond knife, picked up on
formvar-coated 200 mesh nickel grids. For etching resin and remove osmium,
sections were treated with saturated aqueous sodium periodate (NaIO4). They
were then immunostained for Pyk2 with rabbit antibodies (see below) by indirect
immunolabelling protein A-gold probes (20 nm) (CMC Utrecht; Netherlands)
following a published method67. The sections were then double stained with
uranyl acetate and lead citrate before observation with a Philips (CM-100)
electron microscope. Digital images were obtained with a CCD camera
(Gatan Orius). To test the immunostaining speciﬁcity, the primary antibody was
omitted.
Tissue preparation and immunoﬂuorescence. Mice were anaesthetized
(pentobarbital, 60mg kg 1 i.p.) and intracardially perfused with a 40 g l 1
paraformaldehyde solution in 0.1M sodium phosphate, pH 7.2. Brains were
removed and post-ﬁxed overnight in the same paraformaldehyde solution,
cryoprotected with 300 g l 1 sucrose in PBS with 0.2 g l 1 NaN3 and frozen in
dry-ice cooled isopentane. All the following steps were done with gentle shaking.
Serial 30-mm coronal cryostat-free ﬂoating sections were washed three times in
PBS, permeabilized in PBS with 3ml l 1 Triton X-100 and 30ml l 1 normal goat
serum (Pierce Biotechnology, Rockford, IL, USA) for 15min at room temperature,
and washed three times. Brain slices were then incubated overnight at 4 C in the
presence of primary antibodies in PBS with 0.2 g l 1 NaN3: rabbit Pyk2 antibody
(1:500, #07M4755) and mouse MAP2 antibody (1:500) from Sigma, Chemical Co.
(St Louis, MO, USA), mouse antibodies for Htt (clone EM48 1:150, #2026373,
Chemicon, Temecula, CA, USA), mouse anti-PSD-95 1:500 (#QA210648, Thermo
Scientiﬁc, MA, USA). Sections were then washed three times and incubated for 2 h
at room temperature with ﬂuorescent secondary antibodies: Cy3 goat anti-rabbit
(1:200) and/or AlexaFluor 488 goat anti-mouse (1:200; both from Jackson
ImmunoResearch, West Grove, PA, USA). No signal was detected in control
sections incubated in the absence of the primary antibody.
Primary hippocampal neurons culture and immunoﬂuorescence. Hippocampal
neurons were prepared from E17 C57Bl/6 mouse embryos (pregnant mice from
Charles River, Saint Germain Nuelles, France) or from our Pyk2 mice colony as
previously described33. The neuronal cell suspension was seeded (70,000
cells cm 2) on coverslips precoated with poly-D-lysine (0.1mgml 1, Sigma) in
24-well plates or in 6-well plates without coverslips. Neurobasal medium (GIBCO,
Renfrewshire, Scotland, UK) containing 1ml per 50ml of B27 supplement
(Gibco-BRL) and 50ml of GlutaMAX (100 ) (Gibco-BRL) was used to grow the
cells in serum-free medium conditions and maintained at 37 C in 5% CO2. At DIV
21–22, cells were treated with vehicle or 10 mM MK801 (Sigma) for 30min. Then,
cells were treated with vehicle or 40 mM glutamate (Sigma) for 15min and samples
were collected for immunoblot analysis or the glutamate was washed out and
cells further incubated for 3 h before being ﬁxed for 10min with 40 g l 1
paraformaldehyde in PB 0.2M for immunostaining. Fixed cells were permeabilized
in 1ml l 1 Triton X-100 for 10min and then blocking was performed with
10 g l 1 BSA in PBS for 1 h. Cells were incubated with mouse monoclonal
antibodies for PSD-95, (1:500, #QA210648, Millipore) or MAP2 (1:800,
#073M4774, Sigma) or rabbit Pyk2 antibodies (1:500, #074M4755, Sigma, XX)
at 4 C overnight. After three washes with PBS, cells were incubated with the
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corresponding ﬂuorescent secondary antibodies, Cy3 or Cy2 (1:200; Jackson
ImmunoReseach, West Grove, PA). Then, cells were rinsed twice with PBS and
incubated with phalloidin–rhodamine 1:1,000 (Sigma) for 45min in PBS. After
washing twice with PBS, the coverslips were mounted with Vectashield (Vector
Laboratories Burlingam, UK). Hippocampal neuron staining was observed with a
confocal SP5-II (see below).
Cell transfection and constructs. Pyk2þ /þ and Pyk2 / hippocampal neurons
at DIV 18 were transfected using transfectin (Bio-Rad, Hercules, CA, USA)
following the manufacturer’s instructions and left for 48–72 h. Cells were
transfected with previously described constructs38: GFP (control), GFP-Pyk2,
GFP-Pyk21-840 (Pyk2 deleted from the FAT domain and the third proline-rich
motif) and GFP-Pyk2Y402F (Pyk2 with a point mutation of the autophosphorylated
tyrosine-402). GFP was fused to the N terminus of Pyk2.
Confocal imaging and analysis. Immunostained neurons in culture or tissue
sections were imaged using a Leica Confocal SP5-II (63 numerical aperture lens,
5 digital zoom, 1-Airy unit pinhole. Four frames were averaged per z-step
throughout the study. Confocal z-stacks were taken at 1,024 1,024 pixel
resolution, every 2 mm for brain sections and every 0.2 mm for cultured cells. The
labelled PSD95-positive clusters number and size were quantiﬁed with NIH ImageJ
freeware (Wayne Rasband, NIH) as described68 with minor changes. For tissue
sections, at least three 30-mm slices containing dorsal hippocampus were analysed
per mouse and up to three representative CA1 stratum radiatum images were
obtained from each slice. For cultured hippocampal neurons, PSD95-positive
clusters co-localized with F-actin clusters (stained with phalloidin–rodhamine) or
GFP-enriched spines were quantiﬁed as described69 with minor changes using
ImageJ. The number of neurites analysed was420 neurites (one–two neurites per
neuron) per condition from two–three different cultures.
Golgi staining and spine analysis. Fresh brain hemispheres were processed fol-
lowing the Golgi-Cox method as described elsewhere70. Essentially, mouse brain
hemispheres were incubated in the dark for 14–17 days in ﬁltered dye solution
(10 g l 1 K2Cr2O7, 10 g l 1 HgCl2 and 8 g l 1 K2CrO4). The tissue was then
washed 3 2min in water and 30min in 90% EtOH (v/v). Two hundred-mm
sections were cut in 70% EtOH on a vibratome (Leica) and washed in water for
5min. Next, they were reduced in 16% ammonia solution for 1 h before washing in
water for 2min and ﬁxation in 10 g l 1 Na2S2O3 for 7min. After a 2-min ﬁnal
wash in water, sections were mounted on superfrost coverslips, dehydrated for
3min in 50%, then 70, 80 and 100% EtOH, incubated for 2 5min in a 2:1
isopropanol:EtOH mixture, followed by 1 5min in pure isopropanol and
2 5min in xylol. Bright-ﬁeld images of Golgi-impregnated stratum radiatum
dendrites from hippocampal CA1 pyramidal neurons were captured with a Nikon
DXM 1200F digital camera attached to a Nikon Eclipse E600 light microscope
( 100 oil objective). Only fully impregnated pyramidal neurons with their soma
entirely within the thickness of the section were used. Image z-stacks were taken
every 0.2 mm, at 1,024 1,024 pixel resolution, yielding an image with pixel
dimensions of 49.25 49.25 mm. Z-stacks were deconvolved using the Huygens
software (Scientiﬁc volume imaging, Hilversum, the Netherlands) to improve voxel
resolution and to reduce optical aberration along the z axis. Segments of proximal
apical dendrites were selected for the analysis of spine density and spine
morphology according to the following criteria: (a) segments with no overlap with
other branches that would obscure visualization of spines and (b) segments either
‘parallel’ to or ‘at acute angles’ relative to the coronal surface of the section to avoid
ambiguous identiﬁcation of spines. Only spines arising from the lateral surfaces of
the dendrites were included in the study; spines located on the top or bottom of the
dendrite surface were ignored. Given that spine density increases as a function of
the distance from the soma, reaching a plateau 45 mm away from the soma, we
selected dendritic segments of basal dendrites 45 mm away from the cell body. The
total number of spines was obtained using the cell counter tool in the ImageJ
software. At least 60 dendrites per group from at least three mice per genotype were
counted. For a more precise description of the dendritic shape changes, the spine
head diameter was analysed as a continuous distribution (between 368 and 418
spines per group were analysed) using the ImageJ software. Then, a distribution
analysis of head diameter was performed. Then, head diameter analysis was
performed manually using ImageJ for all the spines in control mice. Spine neck was
measured in all spines as the distance from the dendritic shaft to the head of the
spine using the ImageJ.
Subcellular fractionation. Hippocampus from 20-week-old R6/1 mice was
homogenized with a Teﬂon-glass potter in lysis buffer (4mM HEPES, 0.32M
sucrose, 1mM phenylmethylsulfonyl ﬂuoride (PMSF), 10mg l 1 aprotinin,
1mg l 1 leupeptin, 2mM sodium orthovanadate, 0.1 g l 1 benzamidine) and
centrifuged at 3,000 g for 10min. The supernatant was taken as ‘cytosolic’ fraction
and the pellet as ‘nuclear’ fractions. The latter was resuspended in 10mM Tris-HCl
(pH 7.5), 0.25M sucrose, 2mM PMSF, 10mg l 1 aprotinin, 1mg l 1 leupeptin,
2mM Na3VO4 and sonicated. For PSD preparation, the two hippocampi (30–50
mg) of each mouse were homogenized using a Dounce Homogenizer in 1 ml of
homogenization buffer (320 mM sucrose, 1 mM Hepes pH 7.4). Samples were
centrifuged at 1,000 x g for 10 min, 4 C. The pellet was resuspended in 1 ml of
homogenization buffer and centrifuged at 1,000 x g for 10 min, 41C. The two
supernatants were pooled and centrifuged at 18,600 x g for 15 min, 4 C. The pellet
was then resuspended in 1 ml of 1.5 M sucrose, 50 mM Tris-HCl pH 7.4) and
transferred in a 4 ml. Thinwall, ultra-clear Beckman Coulter tube and centrifuged
on a 0.3–0.85 sucrose gradient at 25,000 r.p.m. for 85 min, 4 C (SW60 Ti rotor in
Optima L90K Ultracentrifuge). The synaptosomal fraction was collected at the
interface, resuspended in 2 ml 50 mM Tris-HCl, pH 7.4 and centrifuged at 32,000
r.p.m. for 18 min, 4 C (MLA-80 rotor, Optima Max Ultracentrifuge). The pellet
was resuspended in 1 ml Tris-HCl, 25 mM pH 7.4, 30 ml l-1 Triton X100 and left
on ice for 30 min. Then the sample was loaded onto 2 ml of Tris buffer with 0.85 M
sucrose in a Thinwall, ultra-clear tube and centrifuged at 32,000 r.p.m. for 40 min,
4 C (SW60 Ti rotor in Optima L90K Ultracentrifuge). The pellet corresponding to
the PSD fraction was resuspended in 50 mM Tris-HCl, pH 7.4. Until the gradient
buffers contained 30 mM NaF, 5 mM sodium-orthovanadate, and cOmpleteTM
ULTRA protease inhibitor cocktail (Roche).
Post-mortem human brain tissues. Hippocampal brain tissues were supplied by
the Banc de Teixits Neurolo`gics (Biobanc-HC-IDIBAPS), Barcelona, Spain. They
included six controls (mean±s.e.m.; two females, four males, age 53.5±6.8 years,
post-mortem intervals, 4–18 h), four patients with HD grades 1–2 (four males,
age 72.2±1.7 years post-mortem intervals, 6–14 h) and seven patients with HD
grades 3–4 (three females, four males, age 54.5±6.5 years, post-mortem intervals
of 4–17 h).
Immunoblot analysis. Animals were killed by cervical dislocation. The hippo-
campus was dissected out, frozen using CO2 pellets and stored at  80 C until use.
Brieﬂy, the tissue was lysed by sonication in 250 ml of lysis buffer (PBS, 10ml l 1
Nonidet P-40, 1mM PMSF, 10mg l 1 aprotinin, 1mg l 1 leupeptin and 2mg l 1
sodium orthovanadate). After lysis, samples were centrifuged at 12,000 r.p.m. for
20min. Supernatant proteins (15 mg) from total brain regions extracts were loaded
in SDS–PAGE and transferred to nitrocellulose membranes (GE Healthcare, LC,
UK). Membranes were blocked in TBS-T (150mM NaCl, 20mM Tris-HCl, pH 7.5,
0.5ml l 1 Tween 20) with 50 g l 1 phospho-Blocker (Cell Biolabs, San Diego, CA)
or 50 g l 1 non-fat dry milk and 5 g l 1 BSA. Immunoblots were probed with the
following antibodies (all diluted 1:1,000): rabbit polyclonal antibodies: Pyk2
(#074M4755, Sigma), Pyk2 (#ab32571, Abcam, epitope within the ﬁrst 100 resi-
dues), phosphoY402-Pyk2 (#5), PSD-95 (#QA210648), phosphoY876-GluA2 (#2),
and phosphoY1246-GluN2A (#1, Cell Signaling Technology, Danvers, MA, USA),
GluA1 (#JBC1830522, Upstate Biotechnology, NY, USA), phosphoY1472-GluN2B
(#04242010009761, Cayman antibodies, Ann Arbor, MI, USA), phosphoY418-Src
reacting with all phosphoSFKs (#GR144140-2), and phosphoY1325-GluN2A
(#GR14161032, Abcam, Cambridge, UK), phosphoS831-GluA1 (#2726818),
GluN2B (#2697434), GluA2 (#2280905), and GluN2A (#NRG1815904, Millipore
Bedford, MA, USA), mouse monoclonal antibodies: phosphoERK1/2 (#26,Cell
Signaling Technology, Danvers, MA, USA), FAK (#JBC1900835, Santa Cruz
Biotechnology, Santa Cruz, CA, USA), GluN1 (#225310,Millipore, Bedford, MA,
USA). All blots were incubated with the primary antibody overnight at 4 C by
shaking in PBS with 0.2 g l 1 sodium azide. After several washes in TBS-T,
blots were incubated with secondary anti-rabbit or anti-mouse IgG IRdye800CW-
coupled or anti-mouse IgG IRdye700DX-coupled antibodies (1:2,000, Rockland
Immunochemicals, USA). Secondary antibody binding was detected by Odyssey
infrared imaging apparatus (Li-Cor Inc., Lincoln, NE). For loading control a mouse
monoclonal antibody for a-tubulin was used (#083M4847V, 1:10,000; Sigma).
Statistical analysis. Statistical analyses were carried out using the GraphPad
Prism 6.0 software. Data sets were tested for normality distribution with
d’Agostino–Pearson and Shapiro–Wilk tests. When distribution was not different
from normal, they were analysed with parametric using Student’s t-test (95%
conﬁdence), one-way ANOVA or two-way ANOVA, with Holm–Sidak post hoc
multiple comparisons test. Two by two comparisons were two-tailed. In cases
in which the distribution was signiﬁcantly different from normal (Po0.05),
non-parametric tests were used including Mann and Whitney for two groups
comparisons and Kruskal–Wallis for more than two groups and Dunn’s test for
post hoc multiple comparisons. Kolmogorov–Smirnov test was used as indicated in
the ﬁgure legends. Values of Po0.05 were considered as statistically signiﬁcant.
Data availability. The authors declare that the data supporting the ﬁndings of this
study are available within the paper and its Supplementary Information ﬁles or
available on request from the corresponding author.
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